All news (page 10)

22 September 2026

CATL Debrecen starts trial production in new cell building

Trial operations began 22 Sept 2026 in the new Debrecen cell factory, activating the first two production lines after occupancy and IPPC preconditions were met.
22 September 2026

Shell completes sale of Na Kika and Coulomb interests

Sold 50% Na Kika interest and 100% Coulomb tieback for about $840m; effective date July 1, 2025; buyers are a Talos subsidiary and a Ridgewood affiliate.
22 September 2026

Petrobras uses technical corn oil in asphalt production

Revap has produced 95,000 t of CAP Pro R asphalt using technical corn oil, a semi‑refined residual from corn ethanol processing sourced from Inpasa.
22 September 2026

Arkema inaugurates SMR hydrogen unit at Jarrie

New SMR hydrogen unit commissioned to supply the Jarrie site; €10m investment and first phase of a major plan through 2028 to optimise hydrogen flows and raw‑material supply.
22 September 2026

Amgen: Dazodalibep met Phase 3 primary endpoint in moderate-to-severe Sjögren's disease

Phase 3 trial showed rapid, sustained reduction in systemic disease activity in moderate-to-severe Sjögren's disease with manageable safety signals.
22 September 2026

INEOS idles Hull acetyls complex as gas costs reach 12× US levels

Three world-scale acetyls units in Hull mothballed, threatening nearly 4,000 skilled jobs and eliminating Europe’s last large acetyls capacity amid extreme gas-price disparity.
22 September 2026

Merck updates WINREVAIR label with Phase 3 HYPERION data for newly diagnosed PAH

FDA updates PAH therapy label to include HYPERION data showing a 76% reduction in clinical worsening when added to background therapy for patients diagnosed within 12 months.
22 September 2026

Elkem awarded 1.3 million extra EU ETS allowances for 2021–2025

Follows Norway's finding that domestic producers were under‑allocated versus EU peers; five plants to receive EU‑aligned allocations for 2026–2030.
22 September 2026

ORLEN seeks AI partners from large tech firms and R&D specialists

RFP open to AI vendors with generative AI, ML, data science and industrial deployment experience; Polish firms encouraged; details on Connect platform.
22 September 2026

LANXESS at SEPAWA 2026: preservatives, Cosmelin esters and Scopeblue offerings

Shows preservative solutions for pet care, launches biodegradable Cosmelin esters as a silicone alternative, presents Scopeblue lower‑carbon preservatives and an Oct 16 LCA talk.
22 September 2026

Sulzer supplies DEVO purification unit to BeyondPoly's 100,000 t/y POE plant in China

DEVO™ purification unit commissioned and operating at planned capacity in a new 100,000 t/y POE plant; system reduces residual volatiles while using less energy than alternatives.
22 September 2026

Symrise opens Lautier 1795 production site in Grasse

New production site connects sourcing, transformation, innovation and production, links with Floral Concept and extends local naturals know‑how into Symrise’s global perfumery network.
22 September 2026

Metso secures €40m+ five‑year analyzer LCS deal with South American copper producer

Five‑year outcome‑based analyzer Life Cycle Services contract covering modernization, new analyzers, sampling, spares, digital support and O&M for copper processing.
22 September 2026

Econic launches Recreaire 17RC28 CO2-based ultra-mild surfactant for personal care

Ultra-mild CO2-derived emulsifier with 28% CO2 content and about 25% lower carbon footprint that matches conventional surfactant performance in lotions, creams and haircare.
22 September 2026

Evonik refocuses portfolio and German sites, funds growth via Tailor Made cuts

Aligns businesses by role, assigns roles to six German sites, and shifts investment to Asia/Americas; launches growth projects in Canada and Slovakia, funded by cost cuts.
22 September 2026

MOL completes reconstruction of AV3 unit at Danube Refinery

Fire-damaged crude distillation unit rebuilt with an 18 billion‑forint repair budget; phased restart and safety testing will begin, with production returning in October.
22 September 2026

Worley wins five‑year EPC renewal with CNOOC International UK

Five‑year framework covers EPC across UK Continental Shelf assets including Scott, Buzzard and Golden Eagle; scope ranges from like‑for‑like replacements to complex brownfield works and decommissioning.
21 September 2026

RWE to build 400 MW/1,100 MWh battery at Moerdijk

400 MW/1,100 MWh lithium‑ion battery to supply ~500,000 households for almost three hours; commissioning planned Q2 2028; will relieve Noord‑Brabant grid congestion.
21 September 2026

Genentech: enicepatide Phase II cuts HbA1c and weight in T2D with overweight/obesity

Once‑weekly dual GLP‑1/GIP enicepatide cut HbA1c up to 2.65% and body weight 15.5% at 48 weeks in Phase II; safety aligned with the incretin class.
21 September 2026

POSCO builds next‑generation galvanized automotive steel plant

KRW 480 billion investment for a 450,000 t/yr continuous galvanizing line at Gwangyang; EAF‑linked lower‑carbon, extra‑wide products and AI/robotics for quality and safety.
21 September 2026

Eli Lilly breaks ground on $6.5B Houston API and advanced therapeutics site

New $6.5B Houston plant will make APIs including Foundayo, create 600+ high-wage jobs, and fund $12.5M for workforce training with San Jacinto College.
21 September 2026

EU adopts provisional safeguard measures on grain-oriented electrical steel

Measures effective 25 Sept 2026–end Feb 2027 to curb surging, heavily subsidised GOES imports from Asia and protect the transformer supply chain.
21 September 2026

ORLEN and Naftogaz expand LNG and fuels cooperation

Two MOUs explore three LNG cargoes for Q1 2027, petroleum-product supplies via Ukrnafta, crude processing in Central Europe, and potential transfer of fuel tanker trucks.
21 September 2026

Novo Nordisk: CagriSema outperforms tirzepatide 5 mg for weight loss

CagriSema 1.0/1.0 delivered greater weight loss than tirzepatide 5 mg and 21% vs 2% vs placebo in obesity trial; HbA1c reduction was non‑inferior. FDA decision expected Q4 2026.
21 September 2026

Merck’s KEYTRUDA QLEX approved in Japan for subcutaneous use across all KEYTRUDA indications

First subcutaneous immune‑checkpoint inhibitor in Japan; can be given in as little as one minute and showed comparable exposure and response to IV pembrolizumab in a phase‑3 trial.
21 September 2026

Roche: European Commission approves Susvimo for nAMD

Continuous ranibizumab delivery via the Contivue refillable implant offers an alternative to monthly intravitreal injections, with as few as two treatments per year.
21 September 2026

INA starts up Delayed Coker Unit at Rijeka refinery

New delayed coker boosts diesel yield up to 30%, eliminates VGO imports, and is running at ~70% of design capacity after feedstock was introduced on 1 Sept 2026.
21 September 2026

OMV Petrom advances EUR 560m SAF/HVO unit at Petrobrazi

EUR 560m unit to produce 250,000 t/yr SAF and renewable diesel from vegetable fats and used cooking oils; commissioning targeted for 2028.
21 September 2026

EWE awards Bilfinger contract for Huntorf hydrogen treatment

Engineering, installation and commissioning of an H2 drying system for a 16 million Nm³ repurposed salt cavern; Bilfinger’s H2Dry debuts commercially; operations targeted 2028.
21 September 2026

BASF evaluates MDI plant investment in India

Advanced feasibility study for an MDI complex on secured Dahej land; final decision pending approvals. Project aims to serve India and neighbouring markets with local MDI supply.

← Previous Next →